Business
Special Dividend
Special Dividend.
About this update from B&m European Value Retail Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 0331V\n B&M European Value Retail S.A.\n 09 December 2021\n \n \n \n \n \n \n \n \n 9 December 2021\n \n \n B&M European Value Retail S.A.\n \n \n \n \n \n Announcement of Special Dividend\n \n \n \n \n \n B&M European Value Retail S.A. (the \"Company\") announces that the Board has declared a special dividend of 25.0p per share, equating to approximately £250m in total.\n \n \n \n \n \n At its FY22 Interim results on 11 November 2021, the Company announced continued strong performance versus pre-pandemic levels, with ongoing evaluation of its leverage\n and cash position.\n \n \n \n \n \n As a result of that evaluation, the Board has now determined to return surplus cash to shareholders in line with the Company's capital allocation framework. \n \n \n \n \n \n The special dividend will be paid on 14 January 2022 to shareholders on the register of the Company on 17 December 2021. The Company will provide its Q3 FY22 Trading Update on 11 January 2022.\n \n \n \n \n \n This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation.\n \n \n \n \n \n 1. Dividends are stated as gross amounts before deduction of Luxembourg withholding tax which is currently 15%. \n \n \n \n \n \n \n \n \n Enquiries\n \n \n \n \n \n B&M European Value Retail S.A.\n \n \n For further information please contact +44 (0) 151 728 5400 ext 5763 \n \n \n Simon Arora, Chief Executive \n \n \n Alex Russo, Chief Financial Officer \n \n \n Jonny Armstrong, Head of Investor Relations \n \n \n [email protected]\n \n \n \n \n \n Media\n \n \n For media please contact +44 (0) 207 379 5151\n \n \n Sam Cartwright, Maitland \n \n \n \n [email protected]\n \n \n \n \n \n \n \n \n \n \n \n \n \n This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions...